person · Reporting owner

LEV LB Holdings GP, LLC

Disclosed activity across 1 company

Tapewire entity: 124361
SEC CIK: 0001890132

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LianBioLIAN · Entity 9881	Director · 10% owner	August 18, 2022	August 22, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LianBio

Report date August 18, 2022 · Filed August 22, 2022

Jointly reported with PERCEPTIVE ADVISORS LLC, PERCEPTIVE LIFE SCIENCES MASTER FUND LTD, LEV LB Holdings, LP, Perceptive Xontogeny Venture Fund, LP, C2 Life Sciences LLC, Perceptive Venture Advisors, LLC, EDELMAN JOSEPH

Security / award	Ownership account	Disclosed shares / units	Disclosure context
American Depositary SharesSEC Table I · non-derivative	IndirectSee footnote	3,728,491	Reported balance After 2022-08-18 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-08-18 · Purchase · Acquired 998,240 · Balance 3,728,491 F5: Each American Depositary Share represents one Ordinary Share of the Issuer. F1: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	25,368,895	Reported balance Holding disclosure · report date 2022-08-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 25,368,895 F1: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	21,653,385	Reported balance Holding disclosure · report date 2022-08-18 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 21,653,385 F2: The securities are directly held by LEV LB Holdings, LP ("LEV LB"). LEV LB Holdings GP, LLC ("LEV LB LLC") is the manager of LEV LB. Mr. Edelman is the sole member of LEV LB LLC. LEV LB LLC and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	4,330,675	Reported balance Holding disclosure · report date 2022-08-18 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 4,330,675 F3: The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	2,477,005	Reported balance Holding disclosure · report date 2022-08-18 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 2,477,005 F4: The securities are directly held by C2 Life Sciences LLC ("C2 Life"). The Advisor serves as the investment advisor to C2 Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Filing footnotes · ownership attribution and instrument terms

F1: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

F2: The securities are directly held by LEV LB Holdings, LP ("LEV LB"). LEV LB Holdings GP, LLC ("LEV LB LLC") is the manager of LEV LB. Mr. Edelman is the sole member of LEV LB LLC. LEV LB LLC and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

F3: The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

F4: The securities are directly held by C2 Life Sciences LLC ("C2 Life"). The Advisor serves as the investment advisor to C2 Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

F5: Each American Depositary Share represents one Ordinary Share of the Issuer.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 18, 2022 Filed Aug 22, 2022 13:17 UTC	LianBio LIAN · Entity 9881	PurchaseAmerican Depositary Shares	998,240	$2.40	$2,395,776.00	Disclosure SEC source: 0001062993-22-018544 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,728,491 F5 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
May 26, 2022 Filed May 27, 2022 14:06 UTC	LianBio LIAN · Entity 9881	PurchaseAmerican Depositary Shares	69,000	$3.13	$215,970.00	Disclosure SEC source: 0001062993-22-013616 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,730,251 F5 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.065 to $3.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F6 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
May 25, 2022 Filed May 25, 2022 22:51 UTC	LianBio LIAN · Entity 9881	PurchaseAmerican Depositary Shares	120,000	$2.63	$315,600.00	Disclosure SEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,661,251 F7 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
May 24, 2022 Filed May 25, 2022 22:51 UTC	LianBio LIAN · Entity 9881	PurchaseAmerican Depositary Shares	42,551	$2.47	$105,100.97	Disclosure SEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,541,251 F6 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
May 23, 2022 Filed May 25, 2022 22:51 UTC	LianBio LIAN · Entity 9881	PurchaseAmerican Depositary Shares	8,700	$2.49	$21,663.00	Disclosure SEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,498,700 F5 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionSeries A Preferred Shares · Derivative	423,579	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · derivative · entry 12 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 2,477,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F4 · ownership.nature: The securities are directly held by C2 Life Sciences LLC ("C2 Life"). The Advisor serves as the investment advisor to C2 Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionSeries Seed Preferred Shares · Derivative	500,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · derivative · entry 11 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 2,923,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.exercise_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.expiration_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F3 · ownership.nature: The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionSeries Seed Preferred Shares · Derivative	2,500,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · derivative · entry 10 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 14,619,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.exercise_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.expiration_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F2 · ownership.nature: The securities are directly held by LEV LB Holdings, LP ("LEV LB"). LEV LB Holdings GP, LLC ("LEV LB LLC") is the manager of LEV LB. Mr. Edelman is the sole member of LEV LB LLC. LEV LB LLC and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionSeries Seed Preferred Shares · Derivative	2,500,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · derivative · entry 9 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 14,619,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.exercise_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F6 · derivative.expiration_date: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionSeries A Preferred Shares · Derivative	635,369	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · derivative · entry 8 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 3,715,510 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F5 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionOrdinary Shares	2,477,005	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 7 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,477,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F4 · ownership.nature: The securities are directly held by C2 Life Sciences LLC ("C2 Life"). The Advisor serves as the investment advisor to C2 Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionOrdinary Shares	2,923,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 6 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,330,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F3 · ownership.nature: The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionOrdinary Shares	14,619,500	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 5 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 21,653,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F2 · ownership.nature: The securities are directly held by LEV LB Holdings, LP ("LEV LB"). LEV LB Holdings GP, LLC ("LEV LB LLC") is the manager of LEV LB. Mr. Edelman is the sole member of LEV LB LLC. LEV LB LLC and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionOrdinary Shares	14,619,500	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 4 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 25,588,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the Issuer's Seed Series Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Seed Series Preferred Shares have no expiration date. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	ConversionOrdinary Shares	3,715,510	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,969,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the Issuer's Series A Preferred Shares automatically converted into 5.8478 of the Issuer's Ordinary Shares immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Shares have no expiration date. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 5, 2021 17:47 UTC	LianBio LIAN · Entity 9881	PurchaseOrdinary Shares	20,000	$13.51	$270,200.00	Disclosure SEC source: 0001062993-21-010295 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 27,858,895 F5 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.50 to $13.57, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 03, 2021 Filed Nov 5, 2021 17:47 UTC	LianBio LIAN · Entity 9881	PurchaseOrdinary Shares	2,250,000	$16.00	$36,000,000.00	Disclosure SEC source: 0001062993-21-010295 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 27,838,895 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 02, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	PurchaseOrdinary Shares	100,000	$13.50	$1,350,000.00	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,253,885 F7 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.25 to $13.79, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document
November 01, 2021 Filed Nov 3, 2021 22:59 UTC	LianBio LIAN · Entity 9881	PurchaseOrdinary Shares	120,000	$15.50	$1,860,000.00	Disclosure SEC source: 0000899243-21-042807 · doc4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner LEV LB Holdings, LP · CIK 0001789443 · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · 10% owner C2 Life Sciences LLC · CIK 0001890152 · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,153,885 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.